Class / Patent application number | Description | Number of patent applications / Date published |
424930480 | Enterobacteriaceae | 17 |
20080233094 | Attenuated Salmonella Enterica Serovar Paratyphi a and Uses Thereof - The present invention is drawn to a live, attenuated | 09-25-2008 |
20090324565 | A Colicinogenic Strain of E. Coli - Described herein is the isolation of colicin-producing strains of | 12-31-2009 |
20100135973 | Microorganism Strain CRC2631 of Salmonella typhimurium and its Use as a Cancer Therapeutic - The present invention provides a biologically pure isolate of the genus | 06-03-2010 |
20110020307 | COMPOSITIONS AND METHODS FOR MICROBE STORAGE AND DELIVERY - The present invention relates to the field of bacteriology. In particular, the invention relates to compositions of probiotic microbes and methods for making and using such compositions, e.g. in the treatment and prevention of catheter associated urinary tract infections. | 01-27-2011 |
20110262410 | USE OF LIVE BACTERIA FOR GROWTH PROMOTION IN ANIMALS - The present invention relates to the use of F4 | 10-27-2011 |
20130129694 | USE OF LIVE BACTERIA FOR GROWTH PROMOTION IN ANIMALS - The present invention relates to the use of F4 | 05-23-2013 |
20130323217 | COMPOSITIONS AND METHODS FOR THE CONTROLLED REPOPULATION OF GRAM-NEGATIVE BACTERIA IN THE COLON - The present invention relates to a method for the controlled repopulation of the colonic bacterial flora. | 12-05-2013 |
20140212396 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA - Provided herein are compositions comprising substantially non-viable Gram-negative bacterial organisms that have a substantial reduction in endotoxin activity and/or pyrogenicity and methods for treating a cancer using the same. Also provided are methods for treating cancer provided herein, comprising administering to a mammal diagnosed with cancer, substantially non-viable Gram-negative bacteria having a substantial reduction in endotoxin activity and/or pyrogenicity, in an amount sufficient to inhibit growth or metastasis of the cancer. An additional method is provided comprising administering viable or non-viable Gram-negative bacterial organisms that have a genetic defect that results in a substantial loss of lipopolysaccharide within the outer membrane of the bacteria. Further provided are methods for reducing endotoxin activity and/or pyrogenicity in Gram-negative bacteria comprising treatment with polymyxin and glutaraldehyde. | 07-31-2014 |
20140219977 | USE OF LIVE BACTERIA FOR GROWTH PROMOTION IN ANIMALS - The present invention relates to the use of F4 | 08-07-2014 |
20150110759 | COMPOSITIONS AND METHODS FOR MICROBE STORAGE AND DELIVERY - The present invention relates to the field of bacteriology. In particular, the invention relates to compositions of probiotic microbes and methods for making and using such compositions, e.g. in the treatment and prevention of catheter associated urinary tract infections. | 04-23-2015 |
20150139970 | NOVEL LACTIC ACID BACTERIUM - This invention provides lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect and that can be used with high safety. This invention further provides a pharmaceutical preparation comprising, as an active ingredient, lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect. According to the invention, novel lactic acid bacteria belonging to the | 05-21-2015 |
20150320806 | COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN - The present invention provides compositions and methods for treatment or prevention of pain resulting from infection, infection related pain, and non-infectious pain as well as treatment or prevention of infections or adverse health consequences associated with infections. | 11-12-2015 |
20150373990 | NOVEL BACTERIA AND USES THEREOF - The present invention relates to a novel bacterium | 12-31-2015 |
20160074441 | SALMONELLA STRAINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER - The present invention relates to a pharmaceutical composition comprising a live attenuated non-recombinant mutant of | 03-17-2016 |
20160184456 | ANTICANCER COMBINATIONS - Provided herein, inter alia, are compositions and kits comprising a bacterial cell and a tumor penetrating agent. Also provided are methods of treating cancer in a subject including the step of administering to the subject an effective amount of a bacterial cell and a tumor penetrating agent. Provided are methods of stimulating an immune system in a subject. The methods include administering to the subject an effective amount of a bacterial cell and a tumor penetrating agent. Also provided are methods of enhancing delivery of an anti-cancer agent to a tumor cell including the step of contacting the tumor cell with a bacterial cell, a tumor penetrating agent and an anti-cancer agent. | 06-30-2016 |
20170232046 | NOVEL LACTIC ACID BACTERIUM | 08-17-2017 |
20190142876 | HAFNIA ALVEI BASED PHARMACEUTICAL AND FOOD COMPOSITIONS FOR INDUCING SATIATION AND PROLONGING SATIETY | 05-16-2019 |